News and Announcements
Anteo Signs Licensing Agreement
- Published March 13, 2012 12:14AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
13th March 2012 Companys Announcement Office ASX Limited Exchange Centre 20 Bridge Street Sydney NSW 2000 Anteo signs licensing agreement with leading Life Science Company Agreement for the licensing of MixampGo technology with eBioscience Licensing arrangement for all global markets eBioscience operates in 70 countries and a recognised leader in Life Science reagents Agreement moves MixampGo up value chain to test manufacturers Healthy pipeline of potential commercial agreements 13 March 2012: Anteo Diagnostics Limited (ASX: ADO) is pleased to announce that it has signed a Patent and Technology License Agreement with eBioscience, a leading US headquartered Life Sciences company, providing them with access to Anteos unique MixampGo technology.
—–
To view the full article, please click here.